Published in J Clin Microbiol on February 01, 1992
Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A (2006) 2.51
Does parvovirus B19 have a role in rheumatoid arthritis? Ann Rheum Dis (1994) 1.03
Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions. J Virol (1997) 0.99
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
Use of recombinant human parvovirus B19 antigens in serological assays. J Clin Pathol (1993) 0.78
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 95.08
Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol (1987) 58.68
Calcium-dependent bacteriophage DNA infection. J Mol Biol (1970) 53.43
Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA (1985) 40.01
Dideoxy sequencing method using denatured plasmid templates. Anal Biochem (1986) 17.34
A rapid alkaline extraction method for the isolation of plasmid DNA. Methods Enzymol (1983) 9.81
Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins. EMBO J (1984) 7.60
Parvovirus-like particles in human sera. Lancet (1975) 7.11
Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet (1981) 4.62
Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet (1981) 4.44
Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol (1986) 4.33
Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Lond) (1983) 4.13
Intrauterine parvovirus infection associated with hydrops fetalis. Lancet (1984) 3.99
Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet (1985) 3.82
Human parvovirus arthropathy. Lancet (1985) 3.76
Characteristics and taxonomy of Parvoviridae. Intervirology (1985) 3.70
Inducible expression vectors incorporating the Escherichia coli atpE translational initiation region. Gene (1987) 3.46
An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) (1984) 3.38
Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med (1987) 2.93
Replication of the B19 parvovirus in human bone marrow cell cultures. Science (1986) 2.75
Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol (1987) 2.74
Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med (1987) 2.23
The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg (Lond) (1982) 2.09
An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med (1985) 1.77
Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol (1987) 1.77
Serologically proved intrauterine infection with parvovirus. Br Med J (Clin Res Ed) (1984) 1.70
Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol (1988) 1.62
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 1.51
Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol (1989) 1.37
Parvovirus B19 associated with fetal abnormality. Lancet (1987) 1.37
In vitro identification of a B19 parvovirus promoter. Virology (1987) 1.35
A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci U S A (1989) 1.22
A new peptide for human parvovirus B19 antibody detection. Scand J Infect Dis (1989) 1.19
Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Res (1990) 1.13
Biochemical characterization of a human parvovirus. J Gen Virol (1984) 1.06
Parvovirus infections in pregnancy. Lancet (1986) 1.05
The production of human parvovirus capsid proteins in Escherichia coli and their potential as diagnostic antigens. J Gen Virol (1990) 0.93
Expression of the human parvovirus B19 protein fused to protein A in Escherichia coli: recognition by IgM and IgG antibodies in human sera. J Gen Virol (1989) 0.92
In vitro propagation of parvovirus B19 in primary foetal liver culture. J Gen Virol (1991) 0.89
Enzyme-linked immunosorbent assay for IgG and IgM antibodies against human parvovirus B19: use of monoclonal antibodies and viral antigen propagated in vitro. J Virol Methods (1989) 0.88
New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies. J Clin Microbiol (1991) 0.82
Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J (2000) 4.87
CliniWeb: managing clinical information on the World Wide Web. J Am Med Inform Assoc (1996) 4.13
Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem (2001) 3.15
Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol (2001) 3.11
Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol (2000) 3.02
Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet (1997) 2.86
False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol (1997) 2.84
Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes. Nat Immunol (2001) 2.83
External fibronectin of cultured human fibroblasts is predominantly a matrix protein. J Cell Biol (1978) 2.70
Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev (2000) 2.55
Toxoplasmosis needs evaluation. An overview and proposals. Am J Dis Child (1989) 2.49
Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis (1993) 2.45
Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev (1998) 2.37
Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J Virol (1994) 2.27
Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology (1996) 2.26
Diagnosis of meningococcal meningitis by broad-range bacterial PCR with cerebrospinal fluid. J Clin Microbiol (1998) 2.24
Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers. Cell (1982) 2.20
Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol (1979) 2.19
Detection of influenza A(H3N2) virus in children with suspected mumps during winter 2014/15 in England. Euro Surveill (2015) 2.19
Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol (1988) 1.97
Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology (1996) 1.97
Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol (1999) 1.92
Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol (1998) 1.89
Chlamydial serology in infertile women by immunofluorescence. Fertil Steril (1979) 1.84
Uukuniemi virus maturation: accumulation of virus particles and viral antigens in the Golgi complex. Mol Cell Biol (1982) 1.80
Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem (1996) 1.79
Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication. J Bacteriol (1995) 1.74
Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors. J Gen Virol (2000) 1.73
Microvillus-specific Mr 75,000 plasma membrane protein of human choriocarcinoma cells. J Histochem Cytochem (1987) 1.71
The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Euro Surveill (2012) 1.67
Disseminated toxoplasmosis after liver transplantation: case report and review. Clin Infect Dis (1998) 1.64
Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis (1997) 1.63
Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis (1994) 1.59
Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scand J Infect Dis (1995) 1.56
Bone bank service in Finland. Experience of bacteriologic, serologic and clinical results of the Turku Bone Bank 1972-1995. Acta Orthop Scand (1998) 1.56
Postfixation detergent treatment for immunofluorescence suppresses localization of some integral membrane proteins. J Histochem Cytochem (1985) 1.55
Inhibitory action of fatty acids on the growth of Neisseria gonorrhoeae. Infect Immun (1977) 1.53
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol (1998) 1.48
Chlamydial serum IgG, IgA and local IgA antibodies in patients with genital-tract infections measured by solid-phase radioimmunoassay. J Med Microbiol (1981) 1.47
Clinical significance and outcome of anaerobic bacteremia. Clin Infect Dis (1998) 1.44
Determination of IgG- and IgM-class antibodies to mumps virus by solid-phase enzyme immunoassay. J Virol Methods (1982) 1.41
Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT. Bone Marrow Transplant (2013) 1.41
Acute otitis media and respiratory virus infections. Pediatr Infect Dis J (1989) 1.40
Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis (1995) 1.37
Detection of viral antigens by time-resolved fluoroimmunoassay. Curr Top Microbiol Immunol (1983) 1.33
A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother (2000) 1.33
Fabrication of an ocular prosthesis. J Prosthet Dent (1970) 1.32
Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis (1995) 1.31
Immunoassay diagnosis of adenovirus infections in children. J Clin Microbiol (1983) 1.29
Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proc Natl Acad Sci U S A (1996) 1.29
Immunoglobulin class-specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassay. J Med Virol (1984) 1.28
The interaction of heparin sulfate and adeno-associated virus 2. Virology (2000) 1.28
Diagnosis of respiratory syncytial virus infection in children: comparison of viral antigen detection and serology. J Med Virol (1984) 1.27
Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia. A paradigm of human B19 parvovirus infection. J Clin Invest (1994) 1.26
Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (2001) 1.26
Intracellular vesicles involved in the transport of Semliki Forest virus membrane proteins to the cell surface. EMBO J (1983) 1.26
Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. Blood (2000) 1.25
A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid. Virology (1999) 1.25
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood (2001) 1.24
Clinical considerations improving obturator treatment. J Prosthet Dent (1970) 1.23
An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther (1989) 1.22
Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol (1994) 1.21
Screening for methicillin-resistant Staphylococcus aureus: which anatomical sites to culture? J Hosp Infect (2005) 1.19
Mini-chromosomes derived from the human Y chromosome by telomere directed chromosome breakage. Proc Natl Acad Sci U S A (1996) 1.18
The reliability of diagnosis of infection during revision arthroplasties. Scand J Surg (2002) 1.18
Detection of antiviral IgM antibodies and its problems--a review. Curr Top Microbiol Immunol (1983) 1.18
A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin Diagn Lab Immunol (1999) 1.17
C-reactive protein in respiratory virus infections. J Pediatr (1985) 1.17
Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Dig Dis Sci (2006) 1.16
C reactive protein in the evaluation of febrile illness. Arch Dis Child (1986) 1.16
Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol (2007) 1.15
Rhesus and pig-tailed macaque parvoviruses: identification of two new members of the erythrovirus genus in monkeys. Virology (2000) 1.15
Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group. Pediatr Infect Dis J (1995) 1.15
Fabrication of a hollow-bulb obturator. J Prosthet Dent (1969) 1.14
The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study. Scand J Infect Dis Suppl (1992) 1.13
Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem (1989) 1.13
Rubella infection and reinfection distinguished by avidity of IgG. Lancet (1988) 1.13
Reconstruction considerations for severe dental attrition. J Prosthet Dent (1980) 1.11
Comparison of a simple latex agglutination test with hemolysis-in-gel, hemagglutination inhibition, and radioimmunoassay for detection of rubella virus antibodies. J Clin Microbiol (1985) 1.11
Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect (2000) 1.10
Fever in respiratory virus infections. Am J Dis Child (1986) 1.10
Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection. J Clin Microbiol (1999) 1.09
Sensitive enzyme immunoassay for detecting immunoglobulin M antibodies to Sindbis virus and further evidence that Pogosta disease is caused by a western equine encephalitis complex virus. J Clin Microbiol (1985) 1.08
Integrin alphaVbeta5 is not involved in adeno-associated virus type 2 (AAV2) infection. Virology (1999) 1.08
Retracted GB virus C/hepatitis G virus replicates in human haematopoietic cells and vascular endothelial cells. J Gen Virol (2000) 1.07
Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med (1989) 1.06
Incidence of primary toxoplasma infections during pregnancy in southern Finland: a prospective cohort study. Scand J Infect Dis (1992) 1.06
Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J Gen Virol (2000) 1.06
Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. J Infect Dis (1990) 1.05
Identification of a novel RNA splicing pattern as a basis of restricted cell tropism of erythrovirus B19. Virology (2000) 1.05
Peripheral consideration in improving obturator retention. J Prosthet Dent (1968) 1.04
Reliability and validity of four instruments for measuring lumbar spine and pelvic positions. Phys Ther (1986) 1.04
Adeno-associated virus 2 co-receptors? Nat Med (1999) 1.04
IgA antibody response in acute rubella determined by solid-phase radioimmunoassay. J Hyg (Lond) (1979) 1.03
T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19. J Infect Dis (2001) 1.03
Does parvovirus B19 have a role in rheumatoid arthritis? Ann Rheum Dis (1994) 1.03
Structure and interactions of proteoglycans in the extracellular matrix produced by cultured human fibroblasts. Biochem J (1985) 1.02
Prevalence of the newly described human circovirus, TTV, in United States blood donors. Transfusion (2000) 1.01